Point-of-care & Biosensors

Point-of-care testing (POCT) is necessary for the rapid detection of analytes near to the patient, which facilitates better disease diagnosis, monitoring, and management. Recent years have marked massive advances in point-of-care diagnostics (POCD), which are a result of constant developments in biosensors, microfluidic, bioanalytical platforms, assay formats, lab-on-a-chip technologies, and complementary technologies. This special issue targets the critical advances in POCD and provides guided insights and directions for following research. It permits rapid medical decisions, as the diseases can be diagnosed at a very early stage, directing to improved health outcomes for patients by permiting the early start of treatment. The global POCT market is anticipated to grow from US$ 23.16 in 2016 to US$ 36.96 billion in 2021 at the compound annual growth rate of 9.8% from 2016 to 2021.

 

    Related Conference of Point-of-care & Biosensors

    December 04-05, 2025

    6th International Congress onAI and Machine Learning

    Paris, France
    December 11-12, 2025

    5th Annual Congress on Biofuels and Biopolymers

    Amsterdam, Netherlands
    December 11-12, 2025

    6th World Congress on Robotics and Automation

    Paris, France
    December 11-12, 2025

    24th International Conference on Big Data & Data Analytics

    Amsterdam, Netherlands
    December 17-18, 2025

    7th Annual Summit on Satellite and Space Communication Technology

    Amsterdam, Netherlands
    March 09-10, 2026

    14th Global Summit on Artificial Intelligence and Neural Networks

    Singapore City, Singapore
    April 29-30, 2026

    MECHATRONICS CONFERENCE 2026

    Dubai, UAE

    Point-of-care & Biosensors Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in